I W P C P S^® 5
Fifth International Workshop on Physical Characterization of Pharmaceutical Solids

Preliminary Program

Monday, June 21, 2004 AM
8:00 AM Registration
Subject	Author
Opening Remarks from the Organizer	Angeline Zakrzewski assainternational®
Overview of Modern Solids State Characterization	Franck Leveiller, AstraZeneca, Sweden
POLYMORPHS, SOLVATES AND SALTS: Generation and Characterization Chairperson: Dr. Franck Leveiller, AstraZeneca, Sweden
Choosing the right crystalline form during development: A challenge illustrated by two examples	Michel Bauer, Sanofi Synthelabo, France
Crystallisation of Pharmaceutical Compounds - Methodology and Relation to Solid State Properties	Wolfgang Beckmann, Schering A.G. Germany
Salt form and polymorph screening: Chance to optimize the solid state properties of a drug substance.	Peter Sieger, Boehringer Ingelheim, Germany
High throughput workflow in pre-formulation.	Eva Wu, Symyx Technologies, Inc., USA
The use of increased throughput technologies to investigate solid-state properties of pharmaceutical compounds	James McCabe; Astra-Zeneca, UK
Identifying and producing polymorphs: a rational screening approach	Arjen van Langevelde; Avantium Technologies, The Netherlands
Discussion Round

Monday, June 21, 2004 PM

EXHIBITION OPENING Chairperson: Dr. Angeline Zakrzewski assainternational®

Short Exhibitor Presentation

7:00 p.m. assainternational® RECEPTION

assa reserves the right to change the faculty & agenda to accommodate situations beyond its control.